Role of PCDH10 and its hypermethylation in human gastric cancer

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 2, 2012, Pages 298-305

  Li, Zesong ^a   Chim, James C S ^b   Yang, Mo ^c,d   Ye, Jieyu ^c   Wong, Benjamin C Y ^b   Qiao, Liang ^b,e  

^a THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Gastric cancer; Hypermethylation; PCDH10; Tumor suppressor gene

Indexed keywords

CADHERIN; PROTOCADHERIN 10; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; DEMETHYLATION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STOMACH CANCER;

MUS MUSCULUS;

EID: 84862810286     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.11.011     Document Type: Article

References (26)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. C.A. Cancer J. Clin. 2005, 55:74-108.
2. Lakhani S.R., Ashworth A. Microarray and histopathological analysis of tumours: the future and the past?. Nat. Rev. Cancer 2001, 1:151-157.
3. Baylin S.B., Esteller M., Rountree M.R., Bachman K.E., Schuebel K., Herman J.G. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 2001, 10:687-692.
4. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat. Rev. Cancer 2005, 5:223-231.
5. Jerónimo C. Quantitative methylation profiling of renal tumors and the discovery of a new generation of molecular markers. Future Oncol. 2005, 1:197-200.
6. Laird P.W. The power and the promise of DNA methylation markers. Nat. Rev. Cancer 2003, 3:253-266.
7. Miyamoto K., Fukutomi T., Akashi-Tanaka S., Hasegawa T., Asahara T., Sugimura T., Ushijima T. Identification of 20 genes aberrantly methylated in human breast cancers. Int. J. Cancer 2005, 116:407-414.
8. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J. Gastroenterol. 2006, 12:192-198.
9. Barber M., Fitzgerald R.C., Caldas C. Familial gastric cancer-aetiology and pathogenesis. Best Pract. Res. Clin. Gastroenterol. 2006, 20:721-734.
10. Nollet F., Kools P., van Roy F. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J. Mol. Biol. 2000, 299:551-572.
11. Yagi T., Takeichi M. Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev. 2000, 14:1169-1180.
12. Angst B.D., Marcozzi C., Magee A.I. The cadherin superfamily: diversity in form and function. J. Cell Sci. 2001, 114:629-641.
13. Takeichi M. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 1995, 7:619-627.
14. Wheelock M.J., Johnson K.R. Cadherins as modulators of cellular phenotype. Annu. Rev. Cell Dev. Biol. 2003, 19:207-235.
15. Sano K., Tanihara H., Heimark R.L., Obata S., Davidson M., St.John T., Taketani S., Suzuki S. Protocadherins: a large family of cadherin-related molecules in central nervous system. EMBO J. 1993, 12:2249-2256.
16. Wolverton T., Lalande M. Identification and characterization of three members of a novel subclass of protocadherins. Genomics 2001, 76:66-72.
17. Uemura M., Nakao S., Suzuki S.T., Takeichi M., Hirano S. OL-protocadherin is essential for growth of striatal axons and thalamocortical projections. Nat. Neurosci. 2007, 10:1151-1159.
18. Morrow E.M., Yoo S.Y., Flavell S.W., Kim T.K., Lin Y., Hill R.S., Mukaddes N.M., Balkhy S., Gascon G., Hashmi A., Al-Saad S., Ware J. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008, 321:218-223.
19. Ying J., Gao Z., Li H., Srivastava G., Murray P.G., Goh H.K., Lim C.Y., Wang Y., Marafioti T., Mason D.Y., Ambinder R.F., Chan A.T. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. Br. J. Haematol. 2007, 136:829-832.
20. Ying J., Li H., Seng T.J., Langford C., Srivastava G., Tsao S.W., Putti T., Murray P., Chan A.T., Tao Q. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 2006, 25:1070-1080.
21. Zou B., Chim C.S., Zeng H., Leung S.Y., Yang Y., Tu S.P., Lin M.C., Wang J., He H., Jiang S.H., Sun Y.W., Yu L.F. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Gastroenterology 2006, 131:1835-1843.
22. Qiao L., Dai Y., Gu Q., Chan K.W., Ma J., Lan H.Y., Zou B., Rocken C., Ebert M.P., Wong B.C. Loss of XIAP sensitizes colon cancer cells to PPARγ independent anti-cancer effects of Troglitazone and 15-PGJ2. Cancer Lett. 2008, 268:260-271.
23. Qiao L., Dai Y., Gu Q., Chan K.W., Zou B., Ma J., Wang J., Lan H.Y., Wong B.C. Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer. Mol. Cancer Ther. 2008, 7:2203-2211.
24. Qiao L., Gu Q., Dai Y., Shen Z., Liu X., Qi R., Ma J., Zou B., Li Z., Lan H.Y., Wong B.C. XIAP-associated factor 1 (XAF1) suppresses angiogenesis in mouse endothelial cells. Tumour Biol. 2008, 29:122-129.
25. Qiao L., Zhang H., Yu J., Francisco R., Dent P., Ebert M.P., Rocke C., Farrell G. Constitutive activation of NF-κB in human hepatocellular carcinoma: evidence of a cytoprotective role. Hum. Gene Ther. 2006, 17:280-290.
26. Yu J., Cheng Y.Y., Tao Q., Cheung K.F., Lam C.N., Geng H., Tian L.W., Wong Y.P., Tong J.H., Ying J.M., Jin H., To K.F. Protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology 2009, 136:640-651.e1.